InChI=1S/C45H75N3O33/c1- 11- 24(58) 29(63) 31(65) 41(72- 11) 79- 37- 23(48- 14(4) 55) 40(71- 10- 20- 28(62) 35(22(39(68) 73- 20) 47- 13(3) 54) 78- 42- 32(66) 30(64) 26(60) 17(7- 50) 74- 42) 76- 19(9- 52) 34(37) 77- 43- 33(67) 38(27(61) 18(8- 51) 75- 43) 81- 45(44(69) 70) 5- 15(56) 21(46- 12(2) 53) 36(80- 45) 25(59) 16(57) 6- 49/h11,15- 43,49- 52,56- 68H,5- 10H2,1- 4H3,(H,46,53) (H,47,54) (H,48,55) (H,69,70) /t11- ,15- ,16+,17+,18+,19+,20+,21+,22+,23+,24+,25+,26- ,27- ,28- ,29+,30- ,31- ,32+,33+,34+,35+,36+,37+,38- ,39?,40+,41- ,42- ,43- ,45- /m0/s1 |
NFMNIRJTVILQPB-KSGVFWEVSA-N |
[H] [C@] 1(O[C@@] (C[C@H] (O) [C@H] 1NC(C) =O) (O[C@H] 1[C@@H] (O) [C@@H] (CO) O[C@@H] (O[C@@H] 2[C@@H] (CO) O[C@@H] (OC[C@H] 3OC(O) [C@H] (NC(C) =O) [C@@H] (O[C@@H] 4O[C@H] (CO) [C@H] (O) [C@H] (O) [C@H] 4O) [C@H] 3O) [C@H] (NC(C) =O) [C@H] 2O[C@@H] 2O[C@@H] (C) [C@@H] (O) [C@@H] (O) [C@@H] 2O) [C@@H] 1O) C(O) =O) [C@H] (O) [C@H] (O) CO |
|
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
(via beta-D-Galp-(1->3)-{alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcNAc-(1->6)}-D-GalNAc )
|
|
View more via ChEBI Ontology
Outgoing
|
β- D- Galp- (1→3)- {α- Neup5Ac- (2→3)- β- D- Galp- (1→4)- [α- L- Fucp- (1→3)]- β- D- GlcNAc- (1→6)}- D- GalNAc
(CHEBI:68608)
has role
epitope
(CHEBI:53000)
β- D- Galp- (1→3)- {α- Neup5Ac- (2→3)- β- D- Galp- (1→4)- [α- L- Fucp- (1→3)]- β- D- GlcNAc- (1→6)}- D- GalNAc
(CHEBI:68608)
is a
N-acetylneuraminic acids
(CHEBI:21622)
β- D- Galp- (1→3)- {α- Neup5Ac- (2→3)- β- D- Galp- (1→4)- [α- L- Fucp- (1→3)]- β- D- GlcNAc- (1→6)}- D- GalNAc
(CHEBI:68608)
is a
amino hexasaccharide
(CHEBI:61855)
β- D- Galp- (1→3)- {α- Neup5Ac- (2→3)- β- D- Galp- (1→4)- [α- L- Fucp- (1→3)]- β- D- GlcNAc- (1→6)}- D- GalNAc
(CHEBI:68608)
is a
galactosamine oligosaccharide
(CHEBI:22484)
β- D- Galp- (1→3)- {α- Neup5Ac- (2→3)- β- D- Galp- (1→4)- [α- L- Fucp- (1→3)]- β- D- GlcNAc- (1→6)}- D- GalNAc
(CHEBI:68608)
is a
glucosamine oligosaccharide
(CHEBI:22485)
|
|
Incoming
|
β-D-Gal-(1→3)-{α-Neu5Ac-(2→3)-β-D-Gal-(1→4)-[α-L-Fuc-(1→3)]-β-D-GlcNAc-(1→6)}-α-D-GalNAc
(CHEBI:146205)
is a
β- D- Galp- (1→3)- {α- Neup5Ac- (2→3)- β- D- Galp- (1→4)- [α- L- Fucp- (1→3)]- β- D- GlcNAc- (1→6)}- D- GalNAc
(CHEBI:68608)
|
5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranosonyl- (2→3)- β- D- galactopyranosyl- (1→4)- [6- deoxy- α- L- galactopyranosyl- (1→3)]- 2- acetamido- 2- deoxy- β- D- glucopyranosyl- (1→6)- [β- D- galactopyranosyl- (1→3)]- 2- acetamido- 2- deoxy- D- galactopyranose
|
5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranosonyl- (2→3)- β- D- galactopyranosyl- (1→4)- [α- L- fucopyranosyl- (1→3)]- 2- acetamido- 2- deoxy- β- D- glucopyranosyl- (1→6)- [β- D- galactopyranosyl- (1→3)]- 2- acetamido- 2- deoxy- D- galactopyranose
|
β- D- Gal- (1→3)- {α- Neu5Ac- (2→3)- β- D- Gal- (1→4)- [α- L- Fuc- (1→3)]- β- D- GlcNAc- (1→6)}- D- GalNAc
|
ChEBI
|
Galβ1-3(Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAcβ1-6)GalNAc
|
ChEBI
|
N- acetyl- α- neuraminosyl- (2→3)- β- D- galactosyl- (1→4)- [α- L- fucosyl- (1→3)]- N- acetyl- β- D- glucosaminyl- (1→6)- [β- D- galactosyl- (1→3)]- N- acetyl- D- galactosamine
|
ChEBI
|
WURCS=2.0/5,6,5/[a2112h- 1x_1- 5_2*NCC/3=O][a2112h- 1b_1- 5][a2122h- 1b_1- 5_2*NCC/3=O][a1221m- 1a_1- 5][Aad21122h- 2a_2- 6_5*NCC/3=O]/1- 2- 3- 4- 2- 5/a3- b1_a6- c1_c3- d1_c4- e1_e3- f2
|
GlyTouCan
|
19443021
|
PubMed citation
|
Europe PMC
|
|